Clinical trials for semaglutide have shown fatigue as a side effect, but its usually temporary
The tariff incentive: Similar to other recent drug pricing deals between the administration and pharma companies, Novo and Lilly will get a three-year tariff reprieve, as long as they commit to making more of their products in the US, and have secured FDA priority review vouchers for their oral weight loss treatments
More serious but rare risks include pancreatitis, gallbladder disease, and in diabetes patients, potential worsening of diabetic retinopathy (particularly with semaglutide)
Dose Range: ~2501000 mcg per day during loading, titrated gradually to minimize side effects
N.BlundellT
00:07:21 Vickie Danaher So for instance, the new oral semaglutide for obesity is also approved to reduce the risk of cardiovascular events, such as strokes or heart attacks, in patients with cardiovascular disease and obesity